Shanghai MicroPort Endovascular MedTech Co., Ltd. logo

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016)

Market Open
11 Aug, 06:57
SSE SSE
¥
95. 16
+0.04
+0.0421%
¥
13.33B Market Cap
16.49 P/E Ratio
6.65% Div Yield
488,888 Volume
5.2 Eps
¥ 95.12
Previous Close
Add Transaction
Day Range
94.59 95.85
Year Range
83.33 124.3
Want to track 688016 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688016 trading today higher at ¥95.16, an increase of 0.0421% from yesterday's close, completing a monthly increase of 7.0055% or ¥6.23. Over the past 12 months, 688016 stock gained 3.8185%.
688016 pays dividends to its shareholders, with the most recent payment made on Jun 05, 2026. The next estimated payment will be in In 3 months on Dec 05, 2026 for a total of ¥1.
The last earnings report, released on Apr 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Shanghai MicroPort Endovascular MedTech Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 14, 2024.
The company's stock is traded on one exchange.

688016 Chart

People also search for

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
¥ 140.8
+0.7369%
Shanghai United Imaging Healthcare Co., Ltd.
¥ 112.74
+0.0355%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
¥ 30.71
+0.8207%
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
¥ 140
+2.1898%
Beijing Tiantan Biological Products Co., Ltd.
¥ 12.85
+0.5477%

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016) FAQ

What is the stock price today?

The current price is ¥95.16.

On which exchange is it traded?

Shanghai MicroPort Endovascular MedTech Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688016.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6.65%.

What is its market cap?

As of today, the market cap is 13.33B.

Has Shanghai MicroPort Endovascular MedTech Co., Ltd. ever had a stock split?

Shanghai MicroPort Endovascular MedTech Co., Ltd. had 1 splits and the recent split was on May 14, 2024.

Shanghai MicroPort Endovascular MedTech Co., Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Qing Zhu CEO
SSE Exchange
CNE100003MJ5 ISIN
CN Country
908 Employees
5 Jun 2026 Last Dividend
14 May 2024 Last Split
- IPO Date

Overview

Shanghai MicroPort Endovascular MedTech Co., Ltd. is a prominent player in the medical device sector, focused on advancing the field of aortic and peripheral vascular treatments. Established in 2012 and headquartered in Shanghai, People's Republic of China, the company has dedicated itself to the research, development, manufacturing, and marketing of cutting-edge medical devices both domestically and internationally. Its mission centers on providing innovative solutions that cater to the complex needs of surgical operations involving aortic and peripheral vascular diseases, aiming to improve patient outcomes and enhance the quality of life for those affected by such conditions.

Products and Services

The company's product lineup is rich and diversified, catering to various aspects of aortic and peripheral vascular surgeries:

  • Branched Aortic Stent Graft System: This innovative product is designed for the treatment of complex aortic pathologies, including thoracoabdominal aneurysms. It facilitates a minimally invasive approach by providing a branched framework that ensures the integrity and patency of aortic branches, enhancing patient recovery and outcomes.
  • Thoracic Stent Graft System: Tailored for the repair of thoracic aortic aneurysms and dissections, this system offers a less invasive alternative to traditional open surgery. Its deployment within the thoracic aorta helps to realign and stabilize the aortic wall, significantly reducing the risks associated with these life-threatening conditions.
  • Abdominal Aortic Stent Graft and Delivery System: Specifically designed for abdominal aortic aneurysm repair, this product comprises a stent graft and a specialized delivery system that aids in the precise placement of the stent within the abdominal aorta. This minimally invasive technique helps in preserving the aorta's structure and preventing aneurysm rupture.
  • Bifurcated Stent Graft System: Aimed at treating aortic aneurysms that involve the bifurcation of the aorta into the iliac arteries, this system employs a bifurcated design to ensure blood flow continuity to both legs. This approach minimizes the risk of complications and promotes quicker recovery times for patients.
  • Other Stent Graft System in Surgical Operation: In addition to the primary products, the company offers a repertoire of stent graft systems designed for various other aortic and peripheral vascular surgical interventions. These systems are tailored to meet the unique needs of each operation, ensuring precision, safety, and effectiveness.
  • Accessories, such as Balloon Inflation Catheter: Complementing its stent graft systems, Shanghai MicroPort Endovascular MedTech also provides essential accessories like balloon inflation catheters, which play a critical role in the deployment and placement of stent grafts during endovascular procedures.

Contact Information

Address: No. 1, Lane 3399, Shanghai, China, 201318
Phone: 86 21 3813 9300